期刊文献+

冠状动脉介入诊疗术患者造影剂肾病的危险因素研究 被引量:6

Risk factors of contrast-induced nephropathy in patients undergoing coronary artery intervention
原文传递
导出
摘要 目的研究经皮冠状动脉介入术(PCI)和冠状动脉造影术患者造影剂肾病(CIN)的危险因素。方法选择2008年10月~2009年3月在齐鲁医院接受冠状动脉造影术和/或PCI的200例患者,分别监测造影前3d内(任意1d)和造影后第3、7天的血清肌酐(Scr)、尿素氮(BUN)和尿β2微球蛋白(β2-MG),分析冠状动脉诊疗术患者CIN的危险因素。结果200例患者中,有14例(7%)发生CIN。在CIN组和非CIN组,原有肾功能不全、糖尿病、高血压患者的比例,两组间比较,差异有统计学意义(P<0.05)。年龄、身体质量指数(BMI)、血管紧张素转换酶抑制药(ACEIs)、冠状动脉粥样硬化、造影剂剂量和高脂血症,两组间差异无统计学意义(P>0.05)。logistic多因素逐步回归分析显示原有肾功能不全和糖尿病是CIN的独立危险因素。结论高血压是CIN的一个相关危险因素;年龄、BMI、ACEIs、冠状动脉粥样硬化、造影剂剂量和高脂血症等不是CIN的相关危险因素;原有肾功能不全和糖尿病是CIN的独立危险因素。 Objective To study the risk factors of contrast-induced nephropathy(CIN)in patients undergoing coronary artery angiography and/or percutaneous coronary intervention(PCI).Methods 200 patients undergoing PCI or coronary angiograph from October 2008 to March 2009 were enrolled in this study.Levels of serum creatinine,blood urine nitrogen and urine β2-microglobulin were determined three days before and at 3,7 days after coronary artery intervention.Result Among the 200 patients,14 patients(7%)developed CIN.The incidence of pre-existing renal dysfunction,hypertension,diabetes mellitus in CIN patients and in non-CIN patients did not significantly vary(P〈0.05).Age,body mass index(BMI),angiotensin converting enzyme inhibitors(ACEIs),coronary arteriosclerosis,dosages of contrast agent and hyperlipemia did not significantly vary between the two groups(P〉0.05).Identified by regression,pre-existing renal dysfunction and diabetes mellitus were independent risk factors of CIN.Conclusions Hypertension is one related risk factor of CIN,while age,BMI,ACEIs,coronary arteriosclerosis,dosages of contrast agent and hyperlipemia are not.Pre-existing renal dysfunction and diabetes mellitus are independent risk factors of CIN.
出处 《山东大学学报(医学版)》 CAS 北大核心 2009年第10期98-101,共4页 Journal of Shandong University:Health Sciences
关键词 冠状动脉造影术 经皮冠状动脉介入术 造影剂肾病 危险因素 Coronary artery angiography Percutaneous coronary intervention Contrast-induced nephropathy Risk factors
  • 相关文献

参考文献11

  • 1Briguori C, Airoldi F, Morici N, et al. New Pharmacological protocols toprevent or reduce contrast media nephropathy [ J ]. Minerva Cardioangiol, 2005, 53(1):49-58.
  • 2Cavusoglu E, Chhabra S, Marmur J D, et al. The prevention of contrast-induced nephropathy in patients undergoing percuta- neous coronary intervention[ J ]. Minerva Cardioangiol, 2004, 52(5) :419-432.
  • 3Mc Cullough P A, Adam A, Becker C R, et al. Epidemiology and prognostic implications of contrast-induced nephropathy [J]. Am J Cardiol, 2006, 98(6A):5K-13K.
  • 4Rihal C S, Textor S C, Grill D E, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention [J]. Circulation, 2002, 105(19): 2259- 2264.
  • 5Asff A, Preston R A, Roth D. Radiocontrast-induced nephropathy[J]. Am J Ther, 2003, 10(2):137-147.
  • 6Bartholomew B A, Harjai K J, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification [ J]. Am J Cardiol, 2004, 93 (12) : 1515-1519.
  • 7Toprak O, Cirit M, Yesil M, et al. Impact of diabetic and prediabetic state on development of contrast-induced nephropathy in patients with chronic kodey disease[J]. Nephrol Dial Transplant, 2007, 22(3) : 819-826.
  • 8高亢,赵燕,杨明,王青.造影剂肾病临床相关因素分析[J].中国自然医学杂志,2007,9(4):284-287. 被引量:25
  • 9Cohen D, Buertde G, Perruchoud A P, et al. Hypertension is an independent risk factor for contrast nephropathy after pereutaneous coronary intervention [ J ]. Int J Cardiol, 2006, 110 (2) :237-241.
  • 10Cirit M, Toprak O, Yesil M, et al. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy[J]. Nephron Clin Pract, 2006, 104(1):20-27.

二级参考文献16

  • 1[1]Waybill MM,Waybill PN.Conlrast media-induced nephrotoxicity:identification of patients at risk and algorithms for prevention.Vasc Intervene Radiol,2001,12:3-9.
  • 2[2]McCullough PA,Wolyn R,Racher LL,et al.Acute renal failure after coronary intervention:incidence,risk factor,and relationship to mortality.Am J Med,1997,103:368-375.
  • 3[3]Rihal CS,Textor SC,Grill DE,et al.Incidence and prognostic importance of acute renal failure aster percutaneous coronary intervention.Circulation,2002,105:2259-2264.
  • 4[4]Manske CL,Spralka J,Strony JT,et al.Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography.Am J Med,1990,89:615-620.
  • 5[5]Delay G.Nephrotomixity of contrast media.Nephrol Dial Trannsplant,1999,14:2602-2606.
  • 6[6]Rich MW,Creceleius CA.Incidence,risk factors,and clinical course of acute renal insuffciency after eardiac catheterization in patients 70 years of age or older,Arch Intem Med,1995,1580:1237-1242.
  • 7[7]Weisberg L,Kumik P,Kcnik B.Risk of radiocontrast nephropathy in patients with and without diabetes mellitus.Kidney Int,1994,45:159-165.
  • 8[8]Gruberg L,Mehran R,Dangas G,et al.Acute renal failure requiting dialysis after percutaneous coronary interventions.Cathet Cardiovasc Interven,2001,52:409-416.
  • 9[9]Idee JM,Lancelot E,Berthommier C.Effects of non-ionic monomer and dimeric iodinated contrast media on renal and systemic aerodynamics in rats.Fundam Clin Phamacol,2000,14:11-18.
  • 10[10]Hizoh I,Halle C.Radiocintrast-induced renal tubular cell apoptosis:hypertonic versus stress.Invest Radiol,2002,37:428-434.

共引文献24

同被引文献69

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部